97 related articles for article (PubMed ID: 38657050)
1. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C
Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151
[TBL] [Abstract][Full Text] [Related]
2. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
Jönsson C; Bergram M; Kechagias S; Nasr P; Ekstedt M
Scand J Gastroenterol; 2024 Jun; 59(6):737-741. PubMed ID: 38563432
[TBL] [Abstract][Full Text] [Related]
3. The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study.
Stine JG; Medic N; Pettersson B; Venerus M; Blau JE
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780312
[TBL] [Abstract][Full Text] [Related]
4. Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development.
Chouik Y; Di Filippo M; Radenne S; Dumortier J; Moulin P; Levrero M
Liver Int; 2024 Jun; 44(6):1474-1477. PubMed ID: 38421084
[No Abstract] [Full Text] [Related]
5. PNPLA3 inhibition: Replacing one Evil with the Other?
von Eckardstein A; Gonzalez Melo MJ
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38820113
[No Abstract] [Full Text] [Related]
6. PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease.
Basu Ray S
Adipocyte; 2019 Dec; 8(1):201-208. PubMed ID: 31062641
[TBL] [Abstract][Full Text] [Related]
7. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
[TBL] [Abstract][Full Text] [Related]
8. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
bioRxiv; 2023 Oct; ():. PubMed ID: 37873239
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
[TBL] [Abstract][Full Text] [Related]
10. Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease.
Murray JK; Long J; Liu L; Singh S; Pruitt D; Ollmann M; Swearingen E; Hardy M; Homann O; Wu B; Holder JR; Sham K; Herberich B; Lo MC; Dou H; Shkumatov A; Florio M; Rulifson IC
Nucleic Acid Ther; 2021 Oct; 31(5):324-340. PubMed ID: 34297902
[TBL] [Abstract][Full Text] [Related]
11. The Role of
Liu M; Park S
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674929
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
13. Visualization of Lipid Droplets in the Alveolar Macrophage Cell Line MH-S with Live-cell Imaging by 3D Holotomographic Microscopy (Nanolive).
Pérez-Montero A; Zaragoza O; Luque A; Hortelano S; Acebo P
Bio Protoc; 2023 Mar; 13(5):e4629. PubMed ID: 36908642
[TBL] [Abstract][Full Text] [Related]
14. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis.
Hendriks D; Brouwers JF; Hamer K; Geurts MH; Luciana L; Massalini S; López-Iglesias C; Peters PJ; Rodríguez-Colman MJ; Chuva de Sousa Lopes S; Artegiani B; Clevers H
Nat Biotechnol; 2023 Nov; 41(11):1567-1581. PubMed ID: 36823355
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
